Work

An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice

Year: 2023

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2023.07.061

Authors: Yoshikazu Honda-Okubo, Isaac G. Sakala, Greiciely André, E. Bart Tarbet, Brett L. Hurst, Nikolai Petrovsky

Institutions: Flinders University, Vaxine (Australia), Utah State University

Language: English

Topic: Influenza Virus Research Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Awards: G2898815305, G3611999218, G3831902763, G7037802305, G888847619

OpenAlex ID: W4385398552

FWCI: 1.448

Cites: 53

Cited by: 8

Related to: 10